SEC Form EFFECT filed by Entasis Therapeutics Holdings Inc.
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | July 12, 2022 |
Accession Number: | 0001140361-22-025738 | ||||||
Submission Type: | POS AM | ||||||
|